Navigation Links
Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet
Date:12/1/2009

ors and licensees, including Bayer Schering Pharma, sanofi-aventis, MedImmune, Merck Serono, TRACON and Nycomed, for the funding or conduct of further development and commercialization activities relating to our product candidates. These factors and others are more fully discussed in Micromet's Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2009, filed with the SEC on November 6, 2009, as well as other filings by the company with the SEC.

SOURCE Micromet, Inc.


'/>"/>
SOURCE Micromet, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Simmons Firms Partner Trent Miracle Chosen to Help Lead National Litigation Against Bayer
2. Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimers Disease
3. Bayer Consumer Care Launches Citracal(R) Calcium Plus Heart Health, First-Ever Leading Calcium Supplement to Help Support Bone AND Heart Health
4. Bayer HealthCare Presents Florbetaben Phase II Study Results at World Congress of Neurology
5. Bayer and Onyx Announce Nexavar Data Presentations at 60th American Association for the Study of Liver Diseases Annual Meeting
6. Bayers Novel Anti-Cancer Compound Regorafenib (BAY 73-4506) Showed Stabilization or Regression in 81 Percent of Kidney Cancer Patients
7. Bayer Announces New Data on Oncology Portfolio To Be Presented at the ECCO-ESMO Congress 2009
8. Enrollment Completed in Regeneron and Bayer HealthCare Phase 3 Studies of VEGF Trap-Eye in Neovascular Age-Related Macular Degeneration (Wet AMD)
9. Bayer Announces New Data on Novel Anti-cancer Compound BAY 73-4506
10. Bayer Announces Leukine(R) Data Presentations at 45th American Society of Clinical Oncology (ASCO) Annual Meeting
11. Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... 2015  CryoLife, Inc. (NYSE: CRY ), a ... cardiac and vascular surgery, announced today the appointment of ... Vice President, General Counsel and Corporate Secretary effective April ... Pat Mackin , President and Chief Executive Officer. ... and has extensive legal experience in the medical device ...
(Date:4/1/2015)... , April 1, 2015 Trinity Biotech ... and manufacturer of diagnostic products for the point-of-care ... Biotech Investment Limited, its wholly-owned subsidiary (the "Issuer"), ... considerations, $100 million aggregate principal amount of Exchangeable ... to qualified institutional buyers pursuant to Rule 144A ...
(Date:4/1/2015)... MOUNTAIN VIEW, Calif. , April ... BSX ) announces that it has signed a ... medical device company that develops, manufactures and sells ... transluminal drainage of targeted areas within the gastrointestinal ... week. The Xlumena portfolio includes ...
Breaking Medicine Technology:CryoLife Appoints Jean Holloway as General Counsel 2CryoLife Appoints Jean Holloway as General Counsel 3Trinity Biotech plc Announces Proposed Offering of $100 Million of Exchangeable Senior Notes due 2045 2Trinity Biotech plc Announces Proposed Offering of $100 Million of Exchangeable Senior Notes due 2045 3Trinity Biotech plc Announces Proposed Offering of $100 Million of Exchangeable Senior Notes due 2045 4Boston Scientific Agrees to Acquire Xlumena 2Boston Scientific Agrees to Acquire Xlumena 3Boston Scientific Agrees to Acquire Xlumena 4Boston Scientific Agrees to Acquire Xlumena 5
... ATLANTA, Aug. 23, 2011 TRX, Inc. ( ... travel technology, process automation, consulting and data services, ... solution to several leading companies in the pharmaceutical, ... better ways to manage their travel and procurement ...
... Aug. 23, 2011 PrimeraDx today announced the launch ... on the market used for simultaneous detection and quantification ... and DNA “We are excited to have ... platform,” stated President and CEO Matthew McManus, MD, PhD. ...
Cached Medicine Technology:TRX's Data Intelligence Solution, TRAVELTRAX, Helps Fortune 500 Corporations Gain New Insights Into Cost Savings 2PrimeraDx Launches the Only System Capable of Simultaneous Quantification of mRNA, microRNA and DNA 2
(Date:4/1/2015)... BioPlus Specialty Pharmacy (BioPlus), one ... a new app to keep health care providers informed ... C virus (HCV) infection. This ‘HCV Treatment Path’ app ... American Association for the Study of Liver Diseases (AASLD) ... oral medications to treat HCV have been approved by ...
(Date:4/1/2015)... EAGAN, Minn. (April 1, 2015) —Blue Cross and ... (Blue Cross) today announced audited financial results for 2014. ... of $61.5 million, reflecting positive investment portfolio performance that ... operating loss of $8.2 million on full-year revenues of ... of one percent (0.1%). , Blue Cross reported ...
(Date:4/1/2015)... MD (PRWEB) April 01, 2015 ... free informational seminars in April to discuss the benefits ... for those suffering from periodontal disease. People who ... and suffer from gum disease can now visit Dr. ... to traditional gum surgery. With the LANAP® protocol, which ...
(Date:4/1/2015)... April 01, 2015 Parents of teenaged ... Rehabilitation’s blog, where the latest post discusses Teen Violence ... observation of Teen Dating Violence Awareness Month, the substance ... growing problem to help parents identify if there may ... that might involve drugs or alcohol. , “People learn ...
(Date:4/1/2015)... OSF Saint Paul Medical Center, the ... was welcomed into the Ministry April 1, 2015, with ... E. Showalter, vicar general of the Catholic Diocese of ... a nearly year-long transition process for the former Mendota ... for the morning ceremony included Sister Judith Ann Duvall, ...
Breaking Medicine News(10 mins):Health News:BioPlus Specialty Pharmacy Releases ‘HCV Treatment Path’ App for Hepatitis C Providers 2Health News:Blue Cross and Blue Shield of Minnesota Reports 2014 Results 2Health News:Blue Cross and Blue Shield of Minnesota Reports 2014 Results 3Health News:Dr. Daniel C. Stewart Offers Columbia Area Residents an Informational Seminar in April About Less Invasive Gum Disease Treatment Now Available at Smile Savers Dentistry 2Health News:Dr. Daniel C. Stewart Offers Columbia Area Residents an Informational Seminar in April About Less Invasive Gum Disease Treatment Now Available at Smile Savers Dentistry 3Health News:Best Drug Rehabilitation Issues Toolkit for Teen Violence Related to Substance Abuse 2Health News:Mendota Community Hospital Now OSF Saint Paul Medical Center 2Health News:Mendota Community Hospital Now OSF Saint Paul Medical Center 3
... Jude Childrens Research Hospital study shows that T ... use simple on/off switches to govern the cellular ... they possess sophisticated molecular controls that enable them ... subtle adjustment enables T cells to modulate their ...
... dermatitis, SCHAUMBURG, Ill., May 12 For the ... an important fashion accessory,that many women wear, and change, ... getting more than they bargained for when purchasing,inexpensive earrings. ... dermatitis on the earlobes and repeated exposure can make ...
... to have committed patent and ... trademark ... MTEX ) a leading developer and provider of dietary,supplements and ... the Northern District of Texas found that Glycoproducts,International Inc. had ...
... As part of its,Distinguished Americans series, the U.S. ... that honors Dr. Edward Livingston Trudeau (1848-1915), the,founder ... the Study and,Prevention of Tuberculosis, the precursor to ... to researching and treating tuberculosis, a,highly infectious disease ...
... Occupational and Environmental Medicine, Investigates Relationship of Co-payments, Medication Adherence, ... ... PHILADELPHIA, May 12 High prescription drug,co-payments are associated with ... new study published this month in the,Journal of Occupational and ...
... BOSTON -- In both leukemia and solid tumors, there ... small subgroup that work undercover, patiently lying in wait ... cells (CICs) or leukemia initiating cells (LICs), these stealth ... targeted cancer therapies. When a leukemia patient relapses following ...
Cached Medicine News:Health News:St. Jude study shows how T cell's machinery dials down autoimmunity 2Health News:St. Jude study shows how T cell's machinery dials down autoimmunity 3Health News:Study Finds Nearly One-Third of All Inexpensive Earrings Examined Tested Positive for Nickel 2Health News:Study Finds Nearly One-Third of All Inexpensive Earrings Examined Tested Positive for Nickel 3Health News:Study Finds Nearly One-Third of All Inexpensive Earrings Examined Tested Positive for Nickel 4Health News:Jury Validates Key Mannatech Technology Patents Involving Its Ambrotose(R) Glyconutrient Products 2Health News:Jury Validates Key Mannatech Technology Patents Involving Its Ambrotose(R) Glyconutrient Products 3Health News:American Lung Association Founder Honored With New U.S. Postage Stamp 2Health News:New Study Shows Lowering Co-payments Can Lead to Lower Total Healthcare Costs, Improved Overall Health 2Health News:New Study Shows Lowering Co-payments Can Lead to Lower Total Healthcare Costs, Improved Overall Health 3Health News:New Study Shows Lowering Co-payments Can Lead to Lower Total Healthcare Costs, Improved Overall Health 4Health News:New Study Shows Lowering Co-payments Can Lead to Lower Total Healthcare Costs, Improved Overall Health 5Health News:Arsenic-based therapy shown to help eradicate leukemia-initiating cells 2Health News:Arsenic-based therapy shown to help eradicate leukemia-initiating cells 3
Enzyme Immunoassay of Tissue Plasminogen Activator Antigen by ELISA Method, 96 tests....
Citrated human plasma for the calibration of vWF assays by the immuno-turbidimetric method on STA© analyzers.(STA© Liatest© vWF #0518)....
Heparin-Platelet Factor 4 Induced Antibody...
Control Plasma for Assays of Low MolecularWeight Heparins (LMWH) using Anti-Xa Method on STA© Analyzers....
Medicine Products: